Jeepers Narmac,

We wanted a corporate update and some BETonMACE CKD data and it looks like we are getting a corporate update and some BETonMACE CKD data. Would you rather not have an update and not see new data?

Personally, I am holding back criticism until I have more information from these events next week. I am not happy with the dwindling share price. However, as we all know apabetalone holds A LOT of promise. There are many paths and things can turn around real quick. Now, if next week comes and goes with nothing new, then it's a different story. Until then, maybe try optimism?

BDAZ